Novo Nordisk shares jump 5% as drugmaker sees copycat Wegovy sales easing in 2025 - CNBC
Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.
Search Group
Share To
Comments
About Screade
Screade® Inc. version 0a5de52, copyright 2016 - 2025
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments